Ladenburg Thalmann Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$6.11M Buy
67,988
+6,523
+11% +$585K 0.04% 425
2019
Q3
$5.34M Sell
61,465
-6,615
-10% -$594K 0.04% 439
2019
Q2
$6.25M Sell
68,080
-50,400
-43% -$4.27M 0.05% 395
2019
Q1
$10.2M Buy
118,480
+1,135
+1% +$91.1K 0.08% 239
2018
Q4
$9.02M Buy
117,345
+30,460
+35% +$2.37M 0.08% 226
2018
Q3
$6.71M Sell
86,885
-1,589
-2% -$117K 0.06% 299
2018
Q2
$6.41M Hold
88,474
0.06% 296
2018
Q1
$6.41M Buy
88,474
+707
+0.8% +$53.8K 0.06% 296
2017
Q4
$6.61M Buy
87,767
+141
+0.2% +$10.6K 0.06% 285
2017
Q3
$6.74M Buy
87,626
+2,548
+3% +$192K 0.07% 250
2017
Q2
$6.36M Buy
85,078
+2,976
+4% +$211K 0.07% 244
2017
Q1
$5.46M Sell
82,102
-283
-0.3% -$18.9K 0.07% 255
2016
Q4
$5.41M Buy
82,385
+2,435
+3% +$158K 0.08% 242
2016
Q3
$5.66M Sell
79,950
-795
-1% -$57.9K 0.08% 226
2016
Q2
$5.97M Buy
80,745
+15,006
+23% +$1.04M 0.1% 198
2016
Q1
$4.26M Buy
65,739
+4,817
+8% +$328K 0.08% 244
2015
Q4
$4.7M Buy
60,922
+3,140
+5% +$249K 0.09% 215
2015
Q3
$4.75M Buy
57,782
+8,908
+18% +$793K 0.1% 196
2015
Q2
$4.31M Buy
48,874
+1,620
+3% +$149K 0.08% 237
2015
Q1
$4.18M Buy
47,254
+2,430
+5% +$216K 0.08% 250
2014
Q4
$3.74M Buy
44,824
+13,008
+41% +$1.08M 0.08% 222
2014
Q3
$2.68M Sell
31,816
-246
-0.8% -$19.9K 0.07% 228
2014
Q2
$2.6M Sell
32,062
-580
-2% -$45.6K 0.07% 233
2014
Q1
$2.49M Sell
32,642
-2,501
-7% -$182K 0.07% 211
2013
Q4
$2.53M Buy
35,143
+2,143
+6% +$149K 0.08% 205
2013
Q3
$2.27M Buy
33,000
+2,720
+9% +$180K 0.08% 207
2013
Q2
$1.93M Buy
+30,280
New +$1.97M 0.07% 223

Other funds holding NVS

Ladenburg Thalmann Financial Services's NVS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Novartis (NVS) stake by 11% in Q4 2019, buying an estimated $585K and bringing the position to 67,988 shares worth $6.11M. The position accounts for 0.04% of the portfolio, ranked #425.

Ladenburg Thalmann Financial Services first reported a position in NVS in Q2 2013 and has held it in 27 quarters since. The position peaked at $10.2M in Q1 2019. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 67,988 shares of Novartis worth $6.11M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 6,523 Novartis shares in Q4 2019, an estimated $585K.
  • Novartis made up 0.04% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #425 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Novartis in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Novartis position peaked at $10.2M in Q1 2019.
  • 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.